宫颈癌辐射敏感性相关基因的研究进展

李红艳; 贺桂芳; 陈志华

宫颈癌辐射敏感性相关基因的研究进展

李红艳 , 贺桂芳 , 陈志华

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 1: (44-47)

引用本文:

Citation:

宫颈癌辐射敏感性相关基因的研究进展

1. 100029 北京, 北京中日友好医院临床医学研究所生化分子生物学研究室;
2. 100029 北京, 北京中日友好医院妇产科

通讯作者: 陈志华, chzhihua@sina.com

基金项目:
国家自然科学基金资助项目(30672046)
中图分类号: R730.55

The development of genes associated with radiosensitivity of cervical cancer

1. Department of Biochemistry and Molecular Biology, China-Japan Friendship Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China;
2. Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing 100029, China

Corresponding author: CHEN Zhi-hua, chzhihua@sina.com

CLC number: R730.55

摘要: 放射治疗前,对宫颈癌患者进行辐射敏感性检测以预测放疗效果的研究在肿瘤治疗中有很好的应用前景。根据细胞基因表达水平预测辐射敏感性及基因治疗逆转宫颈癌放射抵抗成为研究热点。影响宫颈癌辐射敏感性的基因主要有细胞增殖、凋亡基因和肿瘤细胞乏氧相关基因等,而基因芯片法分析多个辐射敏感相关基因,对于预测宫颈癌的辐射敏感性和治疗可能更有意义。
- 宫颈肿瘤 /
- 辐射耐受性 /
- 基因
Abstract: It has a good application prospect to predict effeets of radiotherapy by examining radiosensitivity of patients with cervical cancers before their radiotherapy. Prediction of tumor cell radiosensitivity according to their level of gene expression and gene therapy to reverse radio-resistance prior to radiation on cervical cancers are heated researches on tumor therapy. The expression of some proliferation-related genes, apeptosis-related genes and hypoxia-related genes can inerease the radiosensitivity of cervical cancer. Microarray technology may have more direct applications to the study of biological pathway contributing to radiation resistance and may lead to development of alternative treatment modalities.
- Cervical neoplasms /
- Radiation tolerance /
- Gene
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	赵晓利,李力.宫颈癌治疗模式进展.国外医学肿瘤学分册,2004,31(5):380-383.
[2]	Mukherjee G, Freeman A, Moore R, et al. Biologic factor and response to radiotherapy in carcinoma of the cervix. Int J Gynecol Cancer,200t, 11(3):187-193.
[3]	Wootipoom V, Lekhyananda N, Phungrassami T, et al. Prognostic significance of Bar, bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy. Gynecol Oncol, 2004, 94(3):636-642.
[4]	Arafat WO, Gomez-Navarro J, Xiang J, et al. An adenovirus encoding proapoptotic bax induces apoptosis and enhances the radiation effect in human ovarian cancer. Mol Ther, 2001, 1(6):545-554.
[5]	Kokunai T, Urui S, Tomita H, et al. Overcoming of radioresistance in human gliomas by p21^WAF1/CIP1 antisense oligonucleotide. J Neuro Oncol, 2001, 51(2):111-119.
[6]	Suzuki Y, Nakano T, Kato S, et al. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone:p53 status has a strong impact on prognosis. Int J Radiat Oncol Biol Phys, 2004, 60(1):231-236.
[7]	Ishikawa H, Mitsuhashi N, Sakurai H, et al. The effects of p53 status and human papillomavirus infection on the elinical outcome of patients with stage ⅢB cervical carcinoma treated with radiation therapy alone. Cancer, 2001, 91(1):80-89.
[8]	Abdulkarim B, Sabri S, Deutsch E, et al. Antiviral agent cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene, 2002, 21(15):2334-2346.
[9]	苏景伟,于世英,张孟贤,等.p21/^WAF-1/CIP-1与宫颈癌放射敏感性的关系.中华放射肿瘤学杂志,2005,14(1):17-18.
[10]	王建东,高菊珍,杨伟志.增殖细胞核抗原和毛细血管间距与宫颈癌放射敏感性的关系.中华放射肿瘤学杂志,2001,10(2):122-125.
[11]	Cho NH, Kim YB, Park TK, et al. P63 and EGFR as prognosis p redictor in stage ⅡB radiation treated cervical squamous cell cercinoma. Gynecol Oncol, 2003, 91(2):346-353.
[12]	Niibe Y, Nakano T, Ohno T, et al. Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy. Int J Gynecol Cancer, 2003, 13(6):849-855.
[13]	Bachtiary B, Schindl M, Potter R, et al. Overexpression of hypoxiainducible factor-1 alpha indicatas diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res, 2003, 9(6):2234-2240.
[14]	Ishikawa H, Sakurai H, HasegawaM, et al. Expression of hypoxicinducible factor-1 alpha predicts metastasis-free survival after radiation therapy alone in stage Ⅲ B cervical squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 2004, 60(2):513-521.
[15]	Vordermark D, Brown JM. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?. Strahlenther Onkol,2003, 179(12):801-811.
[16]	Airley RE, Loncaster J, Raleigh JA, et al. GLUT-1 and CA IX as intrinsicmarkers of hypoxia in carcinoma of the cervix:relationship to pimonidazole binding. Int J Cancer, 2003, 104(1):85-91.
[17]	Kitahara O, Katagiri T, Tsunoda T, et al. Classification of sensitivity or resistance of cervical cancer to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis.Neoplasia, 2002, 4(4):295-303.
[18]	Harima Y, Togashi A, Horikoshi K, et al. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys, 2004, 60(1):237-248.
[19]	Achary MP, Jaggemauth W, Gross E, et al. Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression. Cytogenet Cell Genet, 2000, 91(1-4):39-43.
[20]	Tewari D, Monk BJ, Al-Ghazi MS, et al. Gene expression profiling of in vitro radiation resistance in cervical carcinoma:a feasibility study. Gynecol Oncol, 2005, 99(1):84-91.

[1]	李俊菲 , 唐梅艳 , 陈欢 , 徐丹 . 异紫堇碱对宫颈癌SiHa细胞增殖和辐射敏感性的影响. 国际放射医学核医学杂志, 2021, 45(5): 291-299. doi: 10.3760/cma.j.cn121381-202004036-00058
[2]	赵舒雅 , 李航 , 樊赛军 . ASTL抗体中和ASTL对人宫颈癌ME-180细胞放射敏感性的影响. 国际放射医学核医学杂志, 2021, 45(12): 773-782. doi: 10.3760/cma.j.cn121381-202009033-00125
[3]	姜勉 , 董佳丽 , 李航 , 樊赛军 . HBXIP蛋白表达对宫颈癌细胞的增殖能力及放射敏感性的影响. 国际放射医学核医学杂志, 2017, 41(5): 340-346. doi: 10.3760/cma.j.issn.1673-4114.2017.05.007
[4]	曾薪宇 , 黄禹豪 , 李素平 . ¹⁸F-FDG PET/CT代谢参数对中晚期宫颈鳞癌转移性淋巴结同步放化疗疗效的预测价值. 国际放射医学核医学杂志, 2023, 47(1): 11-17. doi: 10.3760/cma.j.cn121381-202202005-00253
[5]	焦圣元 , 高巧慧 , 达飞 , 郭利 , 王晋 , 郭娟 , 李静 , 刘军叶 . 缺氧诱导的UCHL5增强宫颈癌Hela细胞辐射抗性. 国际放射医学核医学杂志, 2021, 45(1): 31-40. doi: 10.3760/cma.j.cn121381-202010021-000011
[6]	宋鹏慧 , 武建军 , 汪关雨 , 陈建兵 . TP方案联合同步放疗治疗中晚期宫颈癌疗效及安全性的研究. 国际放射医学核医学杂志, 2024, 48(): 1-7. doi: 10.3760/cma.j.cn121381-202305022-00394
[7]	沈志勇 , 骆华春 , 王玲 , 蔡哲智 , 傅志超 , 朱云云 , 陈忠华 . 新辅助放化疗联合根治性手术在ⅡA1期宫颈癌患者中的应用价值. 国际放射医学核医学杂志, 2022, 46(1): 3-9. doi: 10.3760/cma.j.cn121381-202012022-00146
[8]	訾刚 , 袁超 , 刘红丽 , 李卫鹏 , 李辉 , 沈如月 , 陈雪梅 . ¹⁸F-FDG PET/CT代谢体积参数对复发性宫颈癌的预后预测及其与外周血NLR、PLR相关性的研究. 国际放射医学核医学杂志, 2023, 47(2): 69-80. doi: 10.3760/cma.j.cn121381-202204012-00269
[9]	陈冀莹 . 宫颈癌基因治疗联合放射治疗的研究进展. 国际放射医学核医学杂志, 2006, 30(6): 365-368.
[10]	翟红彦 , 苏成海 . 基因治疗联合放射治疗恶性肿瘤的分子机制. 国际放射医学核医学杂志, 2009, 33(2): 113-116. doi: 10.3760/cma.j.issn.1673-4114.2009.02.015
[11]	李敏 , 孟庆慧 , 胡旭东 , 焦旸 , 徐加英 , 樊赛军 . B细胞易位基因2的表达水平对肿瘤细胞放射敏感性的影响. 国际放射医学核医学杂志, 2013, 37(3): 129-134. doi: 10.3760/cma.j.issn.1673-4114.2013.03.001

点击查看大图

计量

文章访问数: 1465
HTML全文浏览量: 122
PDF下载量: 2

宫颈癌辐射敏感性相关基因的研究进展

通讯作者: 陈志华, chzhihua@sina.com

1. 100029 北京, 北京中日友好医院临床医学研究所生化分子生物学研究室;
2. 100029 北京, 北京中日友好医院妇产科

收稿日期: 2006-08-24

基金项目: 国家自然科学基金资助项目(30672046)

关键词:

摘要: 放射治疗前,对宫颈癌患者进行辐射敏感性检测以预测放疗效果的研究在肿瘤治疗中有很好的应用前景。根据细胞基因表达水平预测辐射敏感性及基因治疗逆转宫颈癌放射抵抗成为研究热点。影响宫颈癌辐射敏感性的基因主要有细胞增殖、凋亡基因和肿瘤细胞乏氧相关基因等,而基因芯片法分析多个辐射敏感相关基因,对于预测宫颈癌的辐射敏感性和治疗可能更有意义。